BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1469695)

  • 1. NMR studies on YSPTSPSY: implications for the design of DNA bisintercalators.
    Harding MM
    J Med Chem; 1992 Dec; 35(25):4658-64. PubMed ID: 1469695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-binding studies of XSPTSPSZ, derivatives of the intercalating heptad repeat of RNA polymerase II.
    Harding MM; Krippner GY; Shelton CJ; Rodger A; Sanders KJ; Mackay JP; Prakash AS
    Biopolymers; 1997 Oct; 42(4):387-98. PubMed ID: 9283289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural studies of a synthetic peptide derived from the carboxyl-terminal domain of RNA polymerase II.
    Cagas PM; Corden JL
    Proteins; 1995 Feb; 21(2):149-60. PubMed ID: 7777490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural differences between the free and bound states of the DNA-bisintercalating peptide YSPTSPSY.
    Khiat A; Lamoureux M; Boulanger Y
    J Med Chem; 1996 Jun; 39(13):2492-8. PubMed ID: 8691446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the YSPTSPS repeat containing two SPXX motifs in the CTD of RNA polymerase II: NMR studies of cyclic model peptides reveal that the SPTS turn is more stable than SPSY in water.
    Kumaki Y; Matsushima N; Yoshida H; Nitta K; Hikichi K
    Biochim Biophys Acta; 2001 Jul; 1548(1):81-93. PubMed ID: 11451441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7.
    Chapman RD; Heidemann M; Albert TK; Mailhammer R; Flatley A; Meisterernst M; Kremmer E; Eick D
    Science; 2007 Dec; 318(5857):1780-2. PubMed ID: 18079404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific threonine-4 phosphorylation and function of RNA polymerase II CTD during M phase progression.
    Hintermair C; Voß K; Forné I; Heidemann M; Flatley A; Kremmer E; Imhof A; Eick D
    Sci Rep; 2016 Jun; 6():27401. PubMed ID: 27264542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural redesign and stabilization of the overlapping tandem beta-turns of RNA polymerase II.
    Dobbins JR; Murali N; Long EC
    Int J Pept Protein Res; 1996 Apr; 47(4):260-8. PubMed ID: 8738651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy.
    O'Neal KD; Chari MV; Mcdonald CH; Cook RG; Yu-Lee LY; Morrisett JD; Shearer WT
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):833-44. PubMed ID: 8645165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformation of the RNA polymerase II C-terminal domain: circular dichroism of long and short fragments.
    Bienkiewicz EA; Moon Woody A; Woody RW
    J Mol Biol; 2000 Mar; 297(1):119-33. PubMed ID: 10704311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1H NMR studies of the solution conformations of an analogue of the C-peptide of ribonuclease A.
    Osterhout JJ; Baldwin RL; York EJ; Stewart JM; Dyson HJ; Wright PE
    Biochemistry; 1989 Aug; 28(17):7059-64. PubMed ID: 2819049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic alpha-helical peptides incorporating intercalators for DNA recognition.
    Brown CL; Harding MM
    J Mol Recognit; 1994 Sep; 7(3):215-20. PubMed ID: 7880546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RNA polymerase II CTD "orphan" residues: Emerging insights into the functions of Tyr-1, Thr-4, and Ser-7.
    Yurko NM; Manley JL
    Transcription; 2018; 9(1):30-40. PubMed ID: 28771071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamic origin of cis/trans isomers of a proline-containing beta-turn model dipeptide in aqueous solution: a combined variable temperature 1H-NMR, two-dimensional 1H,1H gradient enhanced nuclear Overhauser effect spectroscopy (NOESY), one-dimensional steady-state intermolecular 13C,1H NOE, and molecular dynamics study.
    Troganis A; Gerothanassis IP; Athanassiou Z; Mavromoustakos T; Hawkes GE; Sakarellos C
    Biopolymers; 2000 Jan; 53(1):72-83. PubMed ID: 10644952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription.
    Heidemann M; Hintermair C; Voß K; Eick D
    Biochim Biophys Acta; 2013 Jan; 1829(1):55-62. PubMed ID: 22982363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Substrate Identification Method for Human Scp1 Phosphatase Using Phosphorylation Mimic Phage Display.
    Otsubo K; Yoneda T; Kaneko A; Yagi S; Furukawa K; Chuman Y
    Protein Pept Lett; 2018; 25(1):76-83. PubMed ID: 29210629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR studies of model peptides of PHGGGWGQ repeats within the N-terminus of prion proteins: a loop conformation with histidine and tryptophan in close proximity.
    Yoshida H; Matsushima N; Kumaki Y; Nakata M; Hikichi K
    J Biochem; 2000 Aug; 128(2):271-81. PubMed ID: 10920263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisintercalators of DNA with a rigid linker in an extended configuration.
    Mullins ST; Annan NK; Cook PR; Lowe G
    Biochemistry; 1992 Jan; 31(3):842-9. PubMed ID: 1731942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific methylation and acetylation of lysine residues in the C-terminal domain (CTD) of RNA polymerase II.
    Voss K; Forné I; Descostes N; Hintermair C; Schüller R; Maqbool MA; Heidemann M; Flatley A; Imhof A; Gut M; Gut I; Kremmer E; Andrau JC; Eick D
    Transcription; 2015; 6(5):91-101. PubMed ID: 26566685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different phosphoisoforms of RNA polymerase II engage the Rtt103 termination factor in a structurally analogous manner.
    Nemec CM; Yang F; Gilmore JM; Hintermair C; Ho YH; Tseng SC; Heidemann M; Zhang Y; Florens L; Gasch AP; Eick D; Washburn MP; Varani G; Ansari AZ
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E3944-E3953. PubMed ID: 28465432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.